Who is sponsoring NCT04806009?

NCT04806009 is sponsored by Central South University.

What drugs are being tested in NCT04806009?

Interventions in NCT04806009: 'Mindful Living With Insomnia (MLWI)' Intervention via WeChat mini-program, 'Cognitive Behavioral Therapy for insomnia (CBT-I)'via WeChat mini-program.

What condition does NCT04806009 study?

NCT04806009 studies Insomnia, Primary.

Is NCT04806009 still recruiting?

NCT04806009 is currently status unknown. Last updated 19 March 2021.

Last reviewed 2021-03-19 · How we verify

NCT04806009

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluating an Online Mindfulness-Based Intervention for Insomnia

Status unknown NA Last updated 19 March 2021

What this trial tests

NA trial testing 'Mindful Living With Insomnia (MLWI)' Intervention via WeChat mini-program in Insomnia, Primary in 1,000 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
31 December 2022

31 March 2023

Quick facts

Lead sponsor	Central South University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	1,000
Start date	1 January 2022
Primary completion	31 December 2022
Estimated completion	31 March 2023

Drugs / interventions tested

'Mindful Living With Insomnia (MLWI)' Intervention via WeChat mini-program
'Cognitive Behavioral Therapy for insomnia (CBT-I)'via WeChat mini-program

Conditions studied

Insomnia, Primary — all drugs for Insomnia, Primary →

Sponsor

Central South University

Who can join

Adults 18 to 59, any sex, with Insomnia, Primary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Insomnia has significantly negative impact on work, quality of life, psycho-somatic health on individuals and imposes substantial economic burdens on society. Mindfulness-based interventions (MBIs) have shown its efficacy in the treatment of insomnia, however the effect of online MBIs need more studies to verify. This study aims to compare the effectiveness of an online MBI named 'Mindful Living With Insomnia (MLWI)' to online CBI-I for insomnia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

'Mindfulness Living with Insomnia': an mHealth intervention for individuals with insomnia in China: a study protocol of a randomised controlled trial.
Pan C, Tie B, Yuwen W, Su X, et al · · 2022 · cited 4× · PMID 35168972 · DOI 10.1136/bmjopen-2021-053501

Verify or expand the search:

Other recruiting trials for Insomnia, Primary

Currently open trials in the same condition.

NCT06767137 — Comparative Efficacy of BRT and CBT-I for Insomnia · NA · recruiting
NCT06281756 — Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia · EARLY_PHASE1 · recruiting
NCT04953559 — Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep · NA · recruiting
NCT03109210 — Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea · NA · active not recruiting

Other Central South University trials

Trials by the same sponsor.

NCT07444463 — Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications · NA · not yet recruiting
NCT07446478 — TIS for Improving Cognitive Impairment Associated With Schizophrenia · NA · not yet recruiting
NCT07045142 — Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients · Phase 3 · recruiting
NCT07066813 — Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces · recruiting
NCT07063901 — Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04806009 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central South University
Last refreshed: 19 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04806009.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing